Article
Thymidylate synthase expression and genotype have no major impact on the clinical outcome of colorectal cancer patients treated with 5-fluorouracil.
Pharmacological research - 1 Sept 2011
Vignoli Marina, Nobili Stefania, Napoli Cristina, Putignano Anna Laura, Morganti Maria, Papi Laura, Valanzano Rosa, Cianchi Fabio, Tonelli Francesco, Mazzei Teresita, Mini Enrico, Genuardi Maurizio
Abstract excerpt
BACKGROUND AND OBJECTIVES: Thymidylate synthase (TS) expression levels appear to be related to response to 5-fluorouracil-(5-FU)-based chemotherapy in colorectal cancer (CRC) patients. Three polymorphisms have been proposed as modulators of TS expression: a tandemly repeated sequence (2R/3R) in the 5' UTR, a SNP (G>C) within the 3R allele and a 6bp deletion in the 3' UTR. To evaluate the influence of TS...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
